跳至主要内容
临床试验/EUCTR2015-001059-63-DK
EUCTR2015-001059-63-DK进行中(未招募)1 期

BONATHIAD - Bone Association with Thiazide Diuretics. - BONATHIAD

Aalborg University0 个研究点目标入组 175 人开始时间: 2015年3月11日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
175

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Females above the age of 50 and below the age of 85 years of age.
  • Caucasian ethnicity.
  • Menopause for at least two years.
  • Referred to a DXA-scan at the Osteoporosis Clinic at the Department of
  • Endocrinology, Aalborg University Hospital.
  • T-score = -2,5 in total lumbar spine, hip region or femoral neck
  • Prescribed oral alendronic acid of a dose of 70 mg weekly with
  • supplement of Calcum and colecalciferol
  • Appropriate birth control for fertile women as outlined in protocol.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 87
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 87

排除标准

  • Prior traumatic fracture of spine or hip assessed by X-ray or >20%
  • compression fracture assessed by VFA.
  • BMI < 17 og > 30.
  • Prior or current anabolic or antiresorptive osteoporosis treatment other
  • than bisphosphonates after diagnosis.
  • Prior or current use of anticonvulsives, lithium, prednisolon.
  • Prior or current use of thiazides as monotherapy or combination therapy for the previous 5 years
  • Secondary osteoporosis assessed by investigator.
  • Primary bone disease assessed by investigator
  • Renal failure, eGFR < 50 mmol/L/1,73m2.
  • Inability to participate, complete trial or comprehend information as
  • assessed by investigator.
  • Moderate hyponatremia, [Na+] < 130 mmol/L
  • Hypercalcemia, [Ca2+]-albumin adjusted > 2,7 mmol/L

研究者

发起方
Aalborg University

相似试验